Hans‐Jürgen Biersack

Author

Also Known As

Biersack, Hans-Jürgen, Biersack, Hans-Jürgen 1946-, H J Biersack, Hans-Jurgen Biersack, Hans-Jürgen Biersack, Hans‐Jurgen Biersack, Hans‐Jürgen Biersack, Jan Bucerius

108

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

University Hospital Bonn University of Bonn Essen University Hospital Goethe University Frankfurt Oak Ridge National Laboratory

About

Hans‐Jürgen Biersack is an author at University Hospital Bonn specializing in medicine, radiology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	1.4K
2	Health Sciences	13	15	510
3	Engineering	4	4	145
4	Social Sciences	2	2	159
5	Allergy	1	1	106

Hans‐Jürgen Biersack

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours Samer Ezziddin, Feras Khalaf, Maria Vanezi, European Journal of Nuclear Medicine and Molecular Imaging Pancreatic CancerMedicineRadionuclide TherapyPharmacologyAdvanced Grade 1/2	2014	185
Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-Octreotate Samer Ezziddin, Mared Attassi, Charlotte J. Yong‐Hing, Journal of Nuclear Medicine	2014	184
Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-Octreotate Amir Sabet, Khaled Ezziddin, Ulrich‐Frank Pape, Journal of Nuclear Medicine	2013	164
Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate H. Palmedo, Agnieska Manka-Waluch, Peter Albers, Journal of Clinical Oncology	2003	158
Technetium-99m-MIBI scintimammography for suspicious breast lesions. H. Palmedo, A. Schomburg, Frank Grünwald, PubMed	1996	138
The Significance of <sup>99m</sup>Tc-MAA SPECT/CT Liver Perfusion Imaging in Treatment Planning for <sup>90</sup>Y-Microsphere Selective Internal Radiation Treatment Hojjat Ahmadzadehfar, Amir Sabet, Kim Biermann, Journal of Nuclear Medicine	2010	118
Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: An exploratory approach Astrid Zobel, Alexius Joe, Nikolaus Freymann, Psychiatry Research Neuroimaging Exploratory ApproachPsychiatryNeurophysiologyNeuroanatomyMedicine	2005	114
Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001. Uwe Wagner, Siegmund Köhler, Silke Reinartz, PubMed Serious Allergic ReactionsImmunologyImmunoeditingRecurrent Ovarian CancerImmune Cell Therapy	2001	106
Specific efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumours of the small intestine Amir Sabet, Kristina Dautzenberg, Torjan Haslerud, European Journal of Nuclear Medicine and Molecular Imaging Small IntestineMedicineRadionuclide TherapyPathologyRadiopharmaceutical Therapy	2015	102
Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours Amir Sabet, Torjan Haslerud, Ulrich‐Frank Pape, European Journal of Nuclear Medicine and Molecular Imaging MedicineNeuroendocrine DisorderPathologyCancer TreatmentOncology	2013	96

Page 1